PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30908701-0	2019	Undercarboxylated Osteocalcin Improves Insulin-Stimulated Glucose Uptake in Muscles of Corticosterone-Treated Mice.	Corticosterone	87-101	bone gamma-carboxyglutamate protein 2	Mus musculus	18-29	
30908701-7	2019	CS administration reduced both serum osteocalcin and ucOC levels, whole-body insulin sensitivity, and muscle ISGU in EDL.	Corticosterone	0-2	bone gamma-carboxyglutamate protein 2	Mus musculus	37-48	
30979912-5	2019	Corticosterone (CS) treatment resulted in insulin resistance, abnormal fat accrual, loss of lean mass and suppression of serum osteocalcin levels in both genotypes.	Corticosterone	0-14	bone gamma-carboxyglutamate protein 2	Mus musculus	127-138	
30979912-5	2019	Corticosterone (CS) treatment resulted in insulin resistance, abnormal fat accrual, loss of lean mass and suppression of serum osteocalcin levels in both genotypes.	Corticosterone	16-18	bone gamma-carboxyglutamate protein 2	Mus musculus	127-138	
21722764-6	2011	RESULTS: CS suppressed serum OCN levels in WT and tg mice, although they remained higher in tg animals at all time points (p<0.05).	Corticosterone	9-11	bone gamma-carboxyglutamate protein 2	Mus musculus	29-32	
34905510-6	2022	Embryonic not postnatal osteocalcin also governs adrenal growth, adrenal steroidogenesis, blood pressure, electrolyte equilibrium and the rise of circulating corticosterone during the acute stress response in adult offspring.	Corticosterone	158-172	bone gamma-carboxyglutamate protein 2	Mus musculus	24-35